Skip to main content
Top
Published in: Obesity Surgery 1/2008

01-01-2008 | Research Article

Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat Obesity and Associated Diseases

Authors: Sérgio Santoro, Fábio Quirilo Milleo, Carlos Eduardo Malzoni, Sidney Klajner, Pedro C. M. Borges, Marco Aurélio Santo, Fábio Guilherme Campos, Roberto Ferreira Artoni

Published in: Obesity Surgery | Issue 1/2008

Login to get access

Abstract

Background

Recent physiological knowledge allows the design of bariatric procedures that aim at neuroendocrine changes instead of at restriction and malabsorption. Digestive adaptation is a surgical technique for obesity based in this rationale.

Methods

The technique includes a sleeve gastrectomy, an omentectomy and a jejunectomy that leaves initial jejunum and small bowel totaling at least 3 m (still within normal variation of adult human bowel length). Fasting ghrelin and resistin and fasting and postprandial GLP-1 and PYY were measured pre- and postoperatively.

Results

Patients: 228 patients with initial body mass index (BMI) varying from 35 to 51 kg/m2; follow-up: 1 to 5 years; average EBMIL% was 79.7% in the first year; 77.7% in the second year; 71.6% in the third year; 68.9% in the fourth year. Patients present early satiety and major improvement in presurgical comorbidities, especially diabetes. Fasting ghrelin and resistin were significantly reduced (P < 0.05); GLP-1 and PYY response to food ingestion was enhanced (P < 0.05). Surgical complications (4.4%) were resolved without sequela and without mortality. There was neither diarrhea nor detected malabsorption.

Conclusions

Based on physiological and supported by evolutionary data, this procedure creates a proportionally reduced gastrointestinal (GI) tract that amplifies postprandial neuroendocrine responses. It leaves basic GI functions unharmed. It reduces production of ghrelin and resistin and takes more nutrients to be absorbed distally enhancing GLP-1 and PYY secretion. Diabetes was improved significantly without duodenal exclusion. The patients do not present symptoms nor need nutritional support or drug medication because of the procedure, which is safe to perform.
Literature
1.
go back to reference Drazen DL, Woods SC. Peripheral signals in the control of satiety and hunger. Curr Opin Clin Nutr Metabol Care 2003;6:621–9.CrossRef Drazen DL, Woods SC. Peripheral signals in the control of satiety and hunger. Curr Opin Clin Nutr Metabol Care 2003;6:621–9.CrossRef
2.
go back to reference Ranganath LR, Beety JM, Morgan LM, et al. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 1996;38(6):916–9.PubMedCrossRef Ranganath LR, Beety JM, Morgan LM, et al. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 1996;38(6):916–9.PubMedCrossRef
3.
go back to reference Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 2003;994:162–8.PubMedCrossRef Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 2003;994:162–8.PubMedCrossRef
4.
go back to reference Santoro S, Velhote MCP, Malzoni CE, et al. Digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Einstein 2003;1(2):99–104. Santoro S, Velhote MCP, Malzoni CE, et al. Digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Einstein 2003;1(2):99–104.
5.
go back to reference Santoro S, Velhote MCP, Malzoni CE, et al. Preliminary results of digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Sao Paulo Med J 2006;124(4):192–7.PubMedCrossRef Santoro S, Velhote MCP, Malzoni CE, et al. Preliminary results of digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Sao Paulo Med J 2006;124(4):192–7.PubMedCrossRef
6.
go back to reference Santoro S, Malzoni CE, Velhote MCP, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based procedure for morbid obesity. Obes Surg 2006;16(10):1371–79.PubMedCrossRef Santoro S, Malzoni CE, Velhote MCP, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based procedure for morbid obesity. Obes Surg 2006;16(10):1371–79.PubMedCrossRef
8.
go back to reference Kenler HA, Brolin RE, Cody RP. Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am J Clin Nutr 1990;52:87–92.PubMed Kenler HA, Brolin RE, Cody RP. Changes in eating behavior after horizontal gastroplasty and Roux-en-Y gastric bypass. Am J Clin Nutr 1990;52:87–92.PubMed
9.
go back to reference Le Roux CW, Aylwin SJB, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anoretic state, facilitate weight loss and improve metabolic parameters. Ann Surg 2006;243:108–14.PubMedCrossRef Le Roux CW, Aylwin SJB, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anoretic state, facilitate weight loss and improve metabolic parameters. Ann Surg 2006;243:108–14.PubMedCrossRef
10.
go back to reference Stevens CE, Hume ID. Comparative physiology of the vertebrate digestive system. The mammalian gastrointestinal tract. Cambridge, United Kingdom: Cambridge University Press; 1995, p. 46–96. Stevens CE, Hume ID. Comparative physiology of the vertebrate digestive system. The mammalian gastrointestinal tract. Cambridge, United Kingdom: Cambridge University Press; 1995, p. 46–96.
11.
go back to reference Milton K. Primate diets and gut morphology: implications for human evolution. In: Harris M, Ross EB, editors. Food and Evolution. Toward a theory of human food habits. Philadelphia: Temple University Press; 1987. Milton K. Primate diets and gut morphology: implications for human evolution. In: Harris M, Ross EB, editors. Food and Evolution. Toward a theory of human food habits. Philadelphia: Temple University Press; 1987.
12.
go back to reference Milton K. A hypothesis to explain the role of meat-eating in human evolution. Evol Anthropol 1999;8:11–21.CrossRef Milton K. A hypothesis to explain the role of meat-eating in human evolution. Evol Anthropol 1999;8:11–21.CrossRef
13.
go back to reference Aiello LC, Wheeler P. The expensive tissue hypothesis: the brain and the digestive system in human and primate evolution. Curr Anthropol 1995;36:199–221.CrossRef Aiello LC, Wheeler P. The expensive tissue hypothesis: the brain and the digestive system in human and primate evolution. Curr Anthropol 1995;36:199–221.CrossRef
14.
go back to reference Leonard WR, Robertson ML. Evolutionary perspectives on human nutrition: the influence of brain and body size on diet and metabolism. Am J Hum Biol 1994;6:77–88.CrossRef Leonard WR, Robertson ML. Evolutionary perspectives on human nutrition: the influence of brain and body size on diet and metabolism. Am J Hum Biol 1994;6:77–88.CrossRef
15.
go back to reference Lugari R, Dei Cas A, Ugolotti D, et al. Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes. Horm Metab Res 2002;34(3):150–4.PubMedCrossRef Lugari R, Dei Cas A, Ugolotti D, et al. Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes. Horm Metab Res 2002;34(3):150–4.PubMedCrossRef
16.
go back to reference Hounnou G, Destrieux C, Desme J, et al. Anatomical study of the length of the human intestine. Surg Radiol Anat 2002;24(5):290–4.PubMedCrossRef Hounnou G, Destrieux C, Desme J, et al. Anatomical study of the length of the human intestine. Surg Radiol Anat 2002;24(5):290–4.PubMedCrossRef
17.
go back to reference Muccioli G, Tschop M, Papotti M, et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002;440(2–3):235–54.PubMedCrossRef Muccioli G, Tschop M, Papotti M, et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002;440(2–3):235–54.PubMedCrossRef
18.
go back to reference Adkins RB Jr, Davies J. Gross and microscopic anatomy of the stomach and small intestine. In: Scott HW Jr, Sawyers JL, editors. Surgery of the stomach, duodenum and small bowel. Boston: Blackwell Scientific Publications; 1987. p. 45–60. Adkins RB Jr, Davies J. Gross and microscopic anatomy of the stomach and small intestine. In: Scott HW Jr, Sawyers JL, editors. Surgery of the stomach, duodenum and small bowel. Boston: Blackwell Scientific Publications; 1987. p. 45–60.
19.
go back to reference Tolessa T, Gutniak M, Holst JJ, et al. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 1998;102:764–74.PubMed Tolessa T, Gutniak M, Holst JJ, et al. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. J Clin Invest 1998;102:764–74.PubMed
20.
go back to reference Lin HC, Neevel C, Chen JH. Slowing intestinal transit by PYY depends on serotonergic and opioid pathways. Am J Physiol Gastrointest Liver Physiol 2004;286:G558–63.PubMedCrossRef Lin HC, Neevel C, Chen JH. Slowing intestinal transit by PYY depends on serotonergic and opioid pathways. Am J Physiol Gastrointest Liver Physiol 2004;286:G558–63.PubMedCrossRef
21.
go back to reference Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292(14):1724–37.PubMedCrossRef Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292(14):1724–37.PubMedCrossRef
22.
go back to reference Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like peptide-1: a physiological incretin man. Lancet 1987;2(8571):1300–4.PubMedCrossRef Kreymann B, Williams G, Ghatei MA, et al. Glucagon-like peptide-1: a physiological incretin man. Lancet 1987;2(8571):1300–4.PubMedCrossRef
23.
go back to reference Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood–brain barrier. J Mol Neurosci 2002;18:7–14.PubMedCrossRef Kastin AJ, Akerstrom V, Pan W. Interactions of glucagon-like peptide-1 (GLP-1) with the blood–brain barrier. J Mol Neurosci 2002;18:7–14.PubMedCrossRef
24.
go back to reference Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 2003;994:162–8.PubMed Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 2003;994:162–8.PubMed
25.
go back to reference van den Hoek AM, Heijboer AC, Corssmit EP, et al. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 2004;53(8):1949–52.PubMedCrossRef van den Hoek AM, Heijboer AC, Corssmit EP, et al. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 2004;53(8):1949–52.PubMedCrossRef
26.
27.
go back to reference Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999;9(3):223–8.PubMedCrossRef Mason EE. Ileal transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg 1999;9(3):223–8.PubMedCrossRef
28.
go back to reference de Paula AL, Macedo AL, Prudente AS, et al. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)—pilot study of a new operation. Surg Obes Relat Dis 2006;2(4):464–7.PubMedCrossRef de Paula AL, Macedo AL, Prudente AS, et al. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)—pilot study of a new operation. Surg Obes Relat Dis 2006;2(4):464–7.PubMedCrossRef
29.
go back to reference Thulesen J. Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator. Current Protein and Peptide Science 2004;5(1):51–65.PubMedCrossRef Thulesen J. Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator. Current Protein and Peptide Science 2004;5(1):51–65.PubMedCrossRef
30.
go back to reference Thulesen J, Hartmann B, Kissow H, et al. Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection. Dig Dis Sci 2001;46(2):379–88.PubMedCrossRef Thulesen J, Hartmann B, Kissow H, et al. Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection. Dig Dis Sci 2001;46(2):379–88.PubMedCrossRef
31.
go back to reference Santoro S. Hipertrofia intestinal induzida por alimento e obesidade. Einstein 2005;3(4):310–2. Santoro S. Hipertrofia intestinal induzida por alimento e obesidade. Einstein 2005;3(4):310–2.
32.
go back to reference Santoro S, Velhote MCP, Malzoni CE, et al. Preliminary report: adaptive entero-omentectomy: physiological and evolutionary bases of an auxiliary treatment to type 2 diabetes. A report on the first two cases. Einstein 2004;2(3):193–98. Santoro S, Velhote MCP, Malzoni CE, et al. Preliminary report: adaptive entero-omentectomy: physiological and evolutionary bases of an auxiliary treatment to type 2 diabetes. A report on the first two cases. Einstein 2004;2(3):193–98.
33.
go back to reference Milleo FQ, Malafaia O, Nassif PAN, et al. Comparative study of the effect of the Capella and Santoro Type II surgical techniques for treatment of obesity regarding BMI and peripheral triglyceridemia. Rev Bras Videocir 2006;4(4):151–61. Milleo FQ, Malafaia O, Nassif PAN, et al. Comparative study of the effect of the Capella and Santoro Type II surgical techniques for treatment of obesity regarding BMI and peripheral triglyceridemia. Rev Bras Videocir 2006;4(4):151–61.
34.
go back to reference Meier JJ, Gethmann A, Götze O, et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 2006;49:452–8.PubMedCrossRef Meier JJ, Gethmann A, Götze O, et al. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans. Diabetologia 2006;49:452–8.PubMedCrossRef
35.
go back to reference Felber JP. Significance of the Randle-Mechanism in the etiology of diabetes type II. Horm Metab Res Suppl 1990;22:11–7.PubMed Felber JP. Significance of the Randle-Mechanism in the etiology of diabetes type II. Horm Metab Res Suppl 1990;22:11–7.PubMed
36.
go back to reference Rahmouni K, Correia ML, Haynes WG, et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005;45(1):9–14.PubMed Rahmouni K, Correia ML, Haynes WG, et al. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005;45(1):9–14.PubMed
37.
go back to reference Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143–421. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002;106:3143–421.
38.
go back to reference Bergman RN, Van Citters GW, Mittelman SD, et al. Central role of the adipocyte in the metabolic syndrome. J Investig Med 2001;49(1):119–26.PubMedCrossRef Bergman RN, Van Citters GW, Mittelman SD, et al. Central role of the adipocyte in the metabolic syndrome. J Investig Med 2001;49(1):119–26.PubMedCrossRef
39.
go back to reference McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002;359(9300):46–7.PubMedCrossRef McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet 2002;359(9300):46–7.PubMedCrossRef
40.
go back to reference McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002;87(5):2407.PubMedCrossRef McTernan PG, McTernan CL, Chetty R, et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002;87(5):2407.PubMedCrossRef
41.
go back to reference Hansen E, Hajri T, Abunmrad NN. Is all fat the same? The role of fat in the pathogenesis of metabolic syndrome and type 2 diabetes mellitus. Surgery 2006;139(6):711–6.PubMedCrossRef Hansen E, Hajri T, Abunmrad NN. Is all fat the same? The role of fat in the pathogenesis of metabolic syndrome and type 2 diabetes mellitus. Surgery 2006;139(6):711–6.PubMedCrossRef
Metadata
Title
Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat Obesity and Associated Diseases
Authors
Sérgio Santoro
Fábio Quirilo Milleo
Carlos Eduardo Malzoni
Sidney Klajner
Pedro C. M. Borges
Marco Aurélio Santo
Fábio Guilherme Campos
Roberto Ferreira Artoni
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 1/2008
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-007-9371-0

Other articles of this Issue 1/2008

Obesity Surgery 1/2008 Go to the issue